Factors influencing change of preoperative treatment intent in a gastrointestinal cancer practice

od Schwarz, Roderich E
Izdano 2007

Clinical trends and effects on quality metrics for surgical gastroesophageal cancer care

od Schwarz, Roderich E.
Izdano u Transl Gastroenterol Hepatol (2018)

Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum

od Peng, Lan, Schwarz, Roderich E.
Izdano 2012

Profile of nintedanib in the treatment of solid tumors: the evidence to date

od Awasthi, Niranjan, Schwarz, Roderich E
Izdano u Onco Targets Ther (2015)

Vascular challenges from pancreatoduodenectomy in the setting of coeliac artery stenosis

od Beane, Joal D, Schwarz, Roderich E
Izdano u BMJ Case Rep (2017)

Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral operations

od Minarich, Michael J., Schwarz, Roderich E.
Izdano u Transl Gastroenterol Hepatol (2018)

Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer

od Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Izdano 2009

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer

od Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Izdano 2011

Pancreatoduodenectomy with or without Pyloric Preservation: A Clinical Outcomes Comparison

od Dineen, Sean P., Roland, Christina L., Schwarz, Roderich E.
Izdano 2008

AHPBA/SSO/SSAT Sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma

od Dixon, Elijah, Abdalla, Eddie, Schwarz, Roderich E, Vauthey, Jean-Nicolas
Izdano 2010

Augmentation of nab-paclitaxel chemotherapy response by mechanistically diverse antiangiogenic agents in preclinical gastric cancer models

od Awasthi, Niranjan, Schwarz, Margaret A., Zhang, Changhua, Schwarz, Roderich E.
Izdano u Mol Cancer Ther (2018)

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

od ZHANG, CHANG-HUA, AWASTHI, NIRANJAN, SCHWARZ, MARGARET A., SCHWARZ, RODERICH E.
Izdano 2013

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

od Schwarz, Margaret A., Thornton, Janet, Xu, Haiming, Awasthi, Niranjan, Schwarz, Roderich E.
Izdano 2012

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer

od Awasthi, Niranjan, Zhang, Changhua, Ruan, Winston, Schwarz, Margaret A., Schwarz, Roderich E.
Izdano 2012

Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer

od Zhang, Changhua, Awasthi, Niranjan, Schwarz, Margaret A., Hinz, Stefan, Schwarz, Roderich E.
Izdano 2013

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II

od Awasthi, Niranjan, Zhang, Changhua, Hinz, Stefan, Schwarz, Margaret A, Schwarz, Roderich E
Izdano 2013

AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases

od Schwarz, Roderich E, Abdalla, Eddie K, Aloia, Thomas A, Vauthey, Jean-Nicolas
Izdano 2013

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

od Awasthi, Niranjan, Monahan, Sheena, Stefaniak, Alexis, Schwarz, Margaret A., Schwarz, Roderich E.
Izdano u Oncotarget (2017)

The N Terminus of Pro-endothelial Monocyte-activating Polypeptide II (EMAP II) Regulates Its Binding with the C Terminus, Arginyl-tRNA Synthetase, and Neurofilament Light Protein

od Xu, Haiming, Malinin, Nikolay L., Awasthi, Niranjan, Schwarz, Roderich E., Schwarz, Margaret A.
Izdano u J Biol Chem (2015)

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer

od Awasthi, Niranjan, Hinz, Stefan, Brekken, Rolf A., Schwarz, Margaret A., Schwarz, Roderich E.
Izdano u Cancer Lett (2014)